FAQ: Nutriband Inc.'s Inclusion in Russell Indexes and Its Implications

What is the significance of Nutriband Inc. being added to the Russell indexes?

The inclusion reflects market recognition and the momentum behind Nutriband’s AVERSA pipeline, particularly AVERSA Fentanyl, indicating confidence in its potential and growth.

Which Russell indexes has Nutriband Inc. been added to?

Nutriband Inc. has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes.

What is AVERSA Fentanyl and its potential impact?

AVERSA Fentanyl is Nutriband’s lead product under development, an abuse-deterrent fentanyl patch with potential peak annual U.S. sales between $80 million and $200 million.

How does the AVERSA technology work?

AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

What does the inclusion in Russell indexes mean for investors?

It signifies Nutriband’s growing market presence and potential, making it more visible to investment managers and institutions benchmarking against these indexes.

Where can I find more information about Nutriband Inc.?

More information is available on Nutriband’s website at www.Nutriband.com or in the company’s newsroom at https://ibn.fm/NTRB.

What is the estimated asset benchmark of Russell indexes?

Russell indexes benchmark approximately $10.6 trillion in assets, widely used by investment managers and institutions.

Who is the CEO of Nutriband Inc.?

Gareth Sheridan is the CEO of Nutriband Inc.

What is the focus of BioMedWire?

BioMedWire focuses on the latest developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, providing specialized communications and news updates.

How can I receive alerts from BioMedWire?

You can receive SMS alerts from BioMedWire by texting ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only).